Clinical trial
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
NCT06010862
Study timeline
Study start (actual)2023-09-30Date precision: day
Registry last updated2023-11-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Gastric Cancerunresolved
Colon Cancerunresolved
Pancreas Cancerunresolved
Esophagus Cancerunresolved
Cholangiocarcinomaunresolved
Lung Cancerunresolved
Breast Cancerunresolved
Interventions
CEA CAR-T cellsBIOLOGICAL
CEA CAR-T cellsBIOLOGICAL
Sponsors & collaborators
Chongqing Precision Biotech Co., Ltdlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06010862 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.